Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Crude oil ETFs including NEXT FUNDS NOMURA Crude Oil Long rise as WTI hovers near $97 amid negotiation concerns
Crude oil ETFs such as WisdomTree WTI Crude Oil <1690> and NEXT FUNDS NOMURA Crude Oil Long Index Linked Exchange Traded Fund <1699> are trading higher. On the 23rd, U.S. crude oil futures rose, with WTI (West Texas Intermediate) June contracts up $2.89 from the previous day to $95.85 per barrel. Reports emerged that Iranian Parliament Speaker Ghalibaf had stepped down from his negotiating role following intervention by hardline Revolutionary Guards, raising concerns that talks could face difficulties. WTI prices climbed to as high as $98.39 at one point. As of shortly after 10:00 a.m. Japan time on the 24th, prices remain elevated near the $97 level.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
PowerX surges on announcement of 3-for-1 stock split effective May 31
532 stocks advance, 977 decline on Tokyo Stock Exchange Prime Market as of 11 a.m.
Sumitomo Bakelite Company Limited rebounds for first time in three days on plans to expand steering microcatheter production capacity
DAIICHI SANKYO shares fall to 4-year low on earnings announcement delay
Shanghai Composite Index opens at 4,081.0326 on the 24th, down 12.2175 points
STELLA PHARMA CORPORATION rebounds for first time in four days on speculation after Heights Capital disclosed 5.68% stake
YAKULT HONSHA surges to new year-to-date high as U.S. investor Dalton publishes shareholder proposal materials
Hong Kong's Hang Seng Index opens at 25,733.61 on the 24th, down 181.59 points
Umenoyado Brewery debuts at 900 yen, 50% above IPO price
Oncolys BioPharma Inc. <4588> rises as OBP-301 receives FDA fast track designation in U.S.